Inhibition of mouse alveolar macrophage production of tumor necrosis factor alpha by acute in vivo and in vitro exposure to tobacco smoke. 1992

Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
Department of Geriatrics, Faculty of Medicine, University of Tokyo, Japan.

We investigated the effects of tobacco smoke exposure on the production of tumor necrosis factor alpha (TNF alpha) by alveolar macrophages (AM) in mice (C57BL/6). The results obtained are as follows: (1) In vivo tobacco smoke exposure caused a significant decrease in the production of TNF alpha by AM with the stimulation of lipopolysaccharide (LPS; control group: 19.32 +/- 5.52 U/ml, smoked group: 4.28 +/- 0.98 U/ml; p less than 0.05). (2) In vitro exposure of AM to tobacco smoke extracts (water-soluble extracts) also caused a decrease in the production of TNF alpha up to 93% of control with stimulation of LPS (p less than 0.05) without any decrease in cellular viability. We concluded that the production of TNF alpha by AM was impaired by smoking via direct action of the factors present in tobacco smoke.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010947 Plants, Toxic Plants or plant parts which are harmful to man or other animals. Plants, Poisonous,Plant, Poisonous,Plant, Toxic,Poisonous Plant,Poisonous Plants,Toxic Plant,Toxic Plants
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012906 Smoke Visible gaseous suspension of carbon and other particulate matter emitted from burning substances.
D014026 Nicotiana A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; the dried leaves of Nicotiana tabacum are used for SMOKING. Tobacco Plant,Nicotiana tabacum,Plant, Tobacco,Plants, Tobacco,Tobacco Plants
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
February 1990, American journal of respiratory cell and molecular biology,
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
January 1993, Experimental lung research,
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
August 1998, Science (New York, N.Y.),
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
January 1998, Lung,
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
January 2002, Bioorganic & medicinal chemistry,
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
May 1997, Cellular and molecular biology (Noisy-le-Grand, France),
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
February 1994, Archives of surgery (Chicago, Ill. : 1960),
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
March 2000, Toxicology,
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
April 2003, American journal of respiratory and critical care medicine,
Y Higashimoto, and Y Shimada, and Y Fukuchi, and K Ishida, and C Shu, and S Teramoto, and E Sudo, and T Matsuse, and H Orimo
January 1993, Archivum immunologiae et therapiae experimentalis,
Copied contents to your clipboard!